CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Open-market sale President and CEO sold 8,805 shares at $1.57 ($13,824)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,322 shares at $1.57 ($9,926)
- 4 Grant or award COO and CFO acquired 1,200,000 shares (grant or award)
- 4 Open-market sale GENERAL COUNSEL sold 10,278 shares at $1.57 ($16,136)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale PRESIDENT AND CEO sold 9,648 shares at $1.60 ($15,437)
- 4 Open-market sale Chief Financial Officer & PAO sold 7,936 shares at $1.60 ($12,698)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,543 shares at $1.60 ($10,469)
- 4 Open-market sale GENERAL COUNSEL sold 9,769 shares at $1.60 ($15,630)
- 4 Open-market sale Director sold 8,000 shares at $3.16 ($25,280)
- 4 Open-market buy Director bought 23,321 shares at $3.06 ($71,362)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Open-market sale PRESIDENT AND CEO sold 9,923 shares at $3.13 ($31,059)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Open-market sale Chief Financial Officer & PAO sold 8,061 shares at $3.13 ($25,231)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 6,947 shares at an average $3.13 ($21,748)
- 4 Open-market sale GENERAL COUNSEL sold 10,457 shares at an average $3.13 ($32,736)
Page 2 of 12 · 229 filings